Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$34.60
-1.50-4.16%
At close: Dec 15, 4:00 PM EST
$34.00
-0.60-1.73%
After Hours: 6:50 PM EST
Comments
Loading...
Assembly Biosciences Analyst Ratings and Price Targets | NASDAQ:ASMB | Benzinga
Assembly Biosciences Inc has a consensus price target of $42 based on the ratings of 7 analysts. The high is $50 issued by HC Wainwright & Co. on October 14, 2025. The low is $35 issued by Jefferies on September 20, 2024. The 3 most-recent analyst ratings were released by Mizuho, HC Wainwright & Co., and JMP Securities on November 20, 2025, October 14, 2025, and September 24, 2025, respectively. With an average price target of $42.67 between Mizuho, HC Wainwright & Co., and JMP Securities, there's an implied 25.49% upside for Assembly Biosciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Mizuho
HC Wainwright & Co.
JMP Securities
Guggenheim
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Assembly Biosciences
FAQ
What is the target price for Assembly Biosciences (ASMB) stock?
The latest price target for Assembly Biosciences (NASDAQ:ASMB) was reported by Mizuho on November 20, 2025. The analyst firm set a price target for $40.00 expecting ASMB to rise to within 12 months (a possible 17.65% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Assembly Biosciences (ASMB)?
The latest analyst rating for Assembly Biosciences (NASDAQ:ASMB) was provided by Mizuho, and Assembly Biosciences maintained their outperform rating.
When was the last upgrade for Assembly Biosciences (ASMB)?
The last upgrade for Assembly Biosciences Inc happened on September 20, 2024 when Jefferies raised their price target to $35. Jefferies previously had a hold for Assembly Biosciences Inc.
When was the last downgrade for Assembly Biosciences (ASMB)?
There is no last downgrade for Assembly Biosciences.
When is the next analyst rating going to be posted or updated for Assembly Biosciences (ASMB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Assembly Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Assembly Biosciences was filed on November 20, 2025 so you should expect the next rating to be made available sometime around November 20, 2026.
Is the Analyst Rating Assembly Biosciences (ASMB) correct?
While ratings are subjective and will change, the latest Assembly Biosciences (ASMB) rating was a maintained with a price target of $29.00 to $40.00. The current price Assembly Biosciences (ASMB) is trading at is $34.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
